|  Colorado                                                            |   | 84-1509950                             |
|---------------------------------------------------------------------------|--------|----------------------------------------|
| (State or other      jurisdiction of incorporation or organization)  |   | (IRS Employer      Identification No.) |

----

|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |  Page      Number    |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------|
| PART      I.                                                                                                                                                                                               | FINANCIAL      INFORMATION                                                                                                                                                                                                                                                                                                                                 |                      |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| Item      1.                                                                                                                                                                                               | Consolidated      Financial Statements                                                                                                                                                                                                                                                                                                                     |                      |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
|                                                                                                                                                                                                       | Consolidated      Balance Sheet                                                                                                                                                                                                                                                                                                                            | 3-4                       |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
|                                                                                                                                                                                                       | Consolidated      Statements of Operations,                                                                                                                                                                                                                                                                                                                |     5 |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
|                                                                                                                                                                                                       | Consolidated      Statements of Cash Flows                                                                                                                                                                                                                                                                                                                 |     6 |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
|                                                                                                                                                                                                       | Consolidated      Statements of Comprehensive Loss                                                                                                                                                                                                                                                                                                         |    7       |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
|                                                                                                                                                                                                       | Consolidated      Statement of Stockholders’ (Deficit)                                                                                                                                                                                                                                                                                               |     8 |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
|                                                                                                                                                                                                       | Notes      to Unaudited Consolidated Financial Statements                                                                                                                                                                                                                                                                                                  |   9-12          |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| Item      2.                                                                                                                                                                                               | Management's      Discussion and Analysis of Financial Condition and Plan of      Operations                                                                                                                                                                                                                                                               | 13                        |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| Item      3.                                                                                                                                                                                               | Controls      and Procedures                                                                                                                                                                                                                                                                                                                               | 15                        |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| Part      II.                                                                                                                                                                                              | OTHER      INFORMATION                                                                                                                                                                                                                                                                                                                                     |                      |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| Item      1.                                                                                                                                                                                               | Legal      Proceedings                                                       | 15                        |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| Item      2.                                                                                                                                                                                               | Unregistered      Sales of Equity Securities and Use of Proceeds                                                                                                                                                                                                                                                                                           |   16            |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| Item      3.                                                                                                                                                                                               | Defaults      upon Senior Securities                                                                                                                                                                                                                                                                                                                       |   16            |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| Item      4.                                                                                                                                                                                               | Submission      of Matters to a Vote of Security Holders                                                                                                                                                                                                                                                                                                   | 16                        |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| Item      5.                                                                                                                                                                                               | Other      Information                                                                                                                                                                                                                                                                                                                                     |   16            |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| Item      6.                                                                                                                                                                                               | Exhibits      and Reports on Form 8-K                                                                                                                                                                                                                                                                                                                      |   16            |
|                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                       |                      |
| SIGNATURES                                 | 17                                                                                                                                                                                                                                                                                                                                                         |

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|                                                                                   |   | December 31, 2007 |      |   | September 30, 2007 |   |
|----------------------------------------------------------------------------------------|--------|-------------------|-----------|--------|--------------------|--------|
| Assets                                                                                 |   | (Unaudited)       |      |   | (Audited)          |   |
|                                                                                   |   |              |      |   |               |   |
| Current      Assets                                                                    |   |              |      |   |               |   |
|     Cash      and cash equivalents                                 |   | $                 | 811,452   |   |               | $      | 187,536 |   |
|     Accounts      receivable                                       |   |              | 4,923     |   |               |   | 6,937 |   |
|     Inventories                                                    |   |              | 180,074   |   |               |   | 194,826 |   |
|     Research credit      receivable                                |   |              | 116,689   |   |               |   | 127,718 |   |
|     Prepaid      expenses                                          |   |              | 8,508     |   |               |   | 2,764 |   |
|                                                                                   |   |              |      |   |               |   |   |   |
| Total      Current Assets                                                              |   |              | 1,121,646 |   |               |   | 519,781 |   |
|                                                                                   |   |              |      |   |               |   |   |   |
| Property      and Equipment                                                            |   |              |      |   |               |   |   |   |
|     Tooling      and machinery                                     |   |              | 225,175   |   |               |   | 225,175 |   |
|     Furniture and      office equipment                            |   |              | 133,014   |   |               |   | 133,014 |   |
|     Leasehold      improvements                                    |   |              | 22,163    |   |               |   | 22,163 |   |
|                                                                                   |   |              | 380,352   |   |               |   | 380,352 |   |
|                                                                                   |   |              |      |   |               |   |   |   |
|     Less      accumulated depreciation                             |   |              | (259,121  | )      |               |   | (245,536 | ) |
|                                                                                   |   |              |      |   |               |   |   |   |
|                                                                                   |   |              | 121,231   |   |               |   | 134,816 |   |
| Other      Assets                                                                      |   |              |      |   |               |   |   |   |
|     Patents      (net accumulated amortization of $1,043 and $932) |   |              | 982       |   |               |   | 1,098 |   |
|                                                                                   |   |              |      |   |               |   |   |   |
|     Total      Assets                                              |   | $                 | 1,243,859 |   |               | $      | 655,695 |   |
|                                                                                   |   |              |      |   |               |   |   |   |

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|                                                                  |   | December 31, 2007 |       |   | September 30, 2007 |   |
|-----------------------------------------------------------------------|--------|-------------------|------------|--------|--------------------|--------|
|                                                                  |   | (Unaudited)       |       |   | (Audited)          |   |
| Liabilities      and Stockholders' Equity (Deficit)                   |   |              |       |   |               |   |
|                                                                  |   |              |       |   |               |   |
| Current      Liabilities                                              |   |              |       |   |               |   |
|     Unearned      income                          |   | $                 | 1,299,970  |   |               | $      | 7,494 |   |
|     Accounts      payable and accrued expenses    |   |              | 137,350    |   |               |   | 298,152 |   |
|     Loans      payable - related parties          |   |              | 48,852     |   |               |   | 49,696 |   |
|     Current      portion of long-term debts       |   |              | 25,883     |   |               |   | 283,154 |   |
|                                                                  |   |              | 1,512,055  |   |               |   | 638,496 |   |
|     Long-Term      Debts                          |   |              | 12,013     |   |               |   | 14,261 |   |
|                                                                  |   |              |       |   |               |   |   |   |
|                                                                  |   |              |       |   |               |   |   |   |
|                                                                  |   |              |       |   |               |   |   |   |
| Total      Liabilities                                                |   |              | 1,524,068  |   |               |   | 652,757 |   |
|                                                                  |   |              |       |   |               |   |   |   |
| Stockholders'      Equity (Deficit)                                   |   |              |       |   |               |   |   |   |
| Preferred      stock, $.0001 par value; 3,000,000 shares authorized;  |   |              |       |   |               |   |   |   |
| None      issued and outstanding as of December 31, 2007              |   |              |       |   |               |   |   |   |
|                                                                  |   |              |       |   |               |   |   |   |
| Common      stock, $.0001 par value; 100,000,000 shares authorized;   |   |              |       |   |               |   |   |   |
| Issued      and outstanding 27,058,663 shares as of December 31, 2007 |   |              | 2,706      |   |               |   | 2,706 |   |
|                                                                  |   |              |       |   |               |   |   |   |
| Additional      paid-in capital                                       |   |              | 6,804,339  |   |               |   | 6,804,339 |   |
| Deficit                                                               |   |              | (7,144,806 | )      |               |   | (6,971,531 | ) |
| Other      comprehensive income (loss)                                |   |              | 57,552     |   |               |   | 167,424 |   |
|                                                                  |   |              |       |   |               |   |   |   |
| Total      Stockholders' Equity (Deficit)                             |   |              | (280,209   | )      |               |   | 2,938 |   |
|                                                                  |   |              |       |   |               |   |   |   |
|                                                                  |   |              |       |   |               |   |   |   |
| Total      Liabilities and Stockholders' Equity (Deficit)             |   | $                 | 1,243,859  |   |               | $      | 655,695 |   |
|                                                                  |   |              |       |   |               |   |   |   |
|                                                                  |   |              |       |   |               |   |   |   |

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|                                               |   | For theThree-Month Period      Ended |       |
|----------------------------------------------------|--------|--------------------------------------|------------|
|                                               |   | December      31,                    |       |
|                                               |   | 2007                                 |       |   | 2006 |   |
|                                               |   | (Unaudited)                          |       |   | (Unaudited) |   |
|                                               |   |                                 |       |   |   |   |   |   |
| Sales                                              |   | $                                    | 118,592    |   |   | $ | 47,565 |   |
| Cost      of sales                                 |   |                                 | (51,399    | ) |   |   | (26,136 | ) |
|                                               |   |                                 |       |   |   |   |   |   |
| Gross      profit                                  |   |                                 | 67,193     |   |   |   | 21,429 |   |
|                                               |   |                                 |       |   |   |   |   |   |
| Research      and development costs                |   |                                 | (55,064    | ) |   |   | (30,859 | ) |
| Selling,      general, and administrative expenses |   |                                 | (172,059   | ) |   |   | (262,568 | ) |
|                                               |   |                                 | (227,123   | ) |   |   | (293,427 | ) |
|                                               |   |                                 |       |   |   |   |   |   |
| Net      loss from operations                      |   |                                 | (159,930   | ) |   |   | (271,919 | ) |
|                                               |   |                                 |       |   |   |   |   |   |
| Other      Income (Expense)                        |   |                                 |       |   |   |   |   |   |
| Interest      income                               |   |                                 | 768        |   |   |   | --- |   |
| Interest      expense                              |   |                                 | (14,113    | ) |   |   | (5,472 | ) |
|                                               |   |                                 | (13,345    | ) |   |   | (5,472 | ) |
|                                               |   |                                 |       |   |   |   |   |   |
| Net      loss                                      |   | $                                    | (173,275   | ) |   | $ | (277,470 | ) |
|                                               |   |                                 |       |   |   |   |   |   |
| Basic      (loss) per share                        |   | $                                    | (0.006     | ) |   | $ | (0,020 | ) |
|                                               |   |                                 |       |   |   |   |   |   |
| Basic      weighted average shares outstanding     |   |                                 | 27,058,663 |   |   |   | 11,719,137 |   |
|                                               |   |                                 |       |   |   |   |   |   |

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|                                                                                      |   | Three-Month      Period EndedDecember      31, |      |
|-------------------------------------------------------------------------------------------|--------|------------------------------------------------|-----------|
|                                                                                      |   | 2007                                           |      |   | 2006 |   |
| Cash      Flows from Operating Activities                                                 |   |                                           |      |   |   |   |
|        Net Loss                                                                      |   | $                                              | (173,275  | ) |   | $ | (277,470 | ) |
|        Adjustments to reconcile net loss to net cash                                 |   |                                           |      |   |   |   |   |   |
|         Used in operating activities:                                           |   |                                           |      |   |   |   |   |   |
|            Depreciation and amortization expense                 |   |                                           | 13,701    |   |   |   | 11,070 |   |
|            Common stock issued for consulting and legal services |   |                                           | -         |   |   |   | 163,674 |   |
|                                                                                      |   |                                           |      |   |   |   |   |   |
| (Increase)      decrease in Assets                                                        |   |                                           |      |   |   |   |   |   |
|   (Increase) decrease      in accounts receivable                               |   |                                           | 2,014     |   |   |   | (1,113 | ) |
|   Increase (decrease)      in advances to related corporations                  |   |                                           | -         |   |   |   | 1,114 |   |
|   (Increase) decrease      in inventories                                       |   |                                           | 14,752    |   |   |   | (15,374 | ) |
|   (Increase) decrease      in research tax credit receivable                    |   |                                           | 11,029    |   |   |   | 119,069 |   |
|   (Increase) decrease      in prepaid expenses                                  |   |                                           | (5,744    | ) |   |   | 2,965 |   |
|                                                                                      |   |                                           |      |   |   |   |   |   |
| Increase      (decrease) in Liabilities                                                   |   |                                           |      |   |   |   |   |   |
|   Increase (decrease)      in unearned income                                   |   |                                           | 1,292,476 |   |   |   | (14,132 | ) |
|   Increase (decrease)      in accounts payable and accrued expenses             |   |                                           | (160,802  | ) |   |   | (12,296 | ) |
|                                                                                      |   |                                           |      |   |   |   |   |   |
|   Net Cash Provided      by (Used in) Operating Activities                      |   |                                           | 994,151   |   |   |   | (22,493 | ) |
|                                                                                      |   |                                           |      |   |   |   |   |   |
| Cash      Flows from Financing Activities                                                 |   |                                           |      |   |   |   |   |   |
|         Gross proceeds from private offering                                    |   |                                           | -         |   |   |   | 15,000 |   |
|         Reduction in amounts due to related parties                             |   |                                           | (844      | ) |   |   | - |   |
|         Principal reduction on small business loan                              |   |                                           | (259,519  | ) |   |   | - |   |
|                                                                                      |   |                                           |      |   |   |   |   |   |
|   Net Cash Provided      by Financing Activities                                |   |                                           | (260,363  | ) |   |   | 15,000 |   |
|                                                                                      |   |                                           |      |   |   |   |   |   |
| Effect      of exchange rates on cash                                                     |   |                                           | (109,872  | ) |   |   | 2,139 |   |
|                                                                                      |   |                                           |      |   |   |   |   |   |
| Net      Increase (decrease) in Cash and Cash Equivalents                                 |   |                                           | 623,916   |   |   |   | 9,632 |   |
|                                                                                      |   |                                           |      |   |   |   |   |   |
| Beginning      Balance - Cash and Cash Equivalents                                        |   |                                           | 187,536   |   |   |   | 2,920 |   |
|                                                                                      |   |                                           |      |   |   |   |   |   |
| Ending      Balance - Cash and Cash Equivalents                                           |   | $                                              | 811,452   |   |   | $ | 12,552 |   |
|                                                                                      |   |                                           |      |   |   |   |   |   |
| Supplemental      Information:                                                            |   |                                           |      |   |   |   |   |   |
|                                                                                      |   |                                           |      |   |   |   |   |   |
| Cash Paid      For:                                                                       |   |                                           |      |   |   |   |   |   |
|   Interest      Expenses                                                        |   | $                                              | 14,112    |   |   | $ | 1,591 |   |
|   Income      Taxes                                                             |   | $                                              | -         |   |   | $ | - |   |

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|                                                     |   | First      quarter ending   |     |   | For      the year ending     |   |
|----------------------------------------------------------|--------|-----------------------------|----------|--------|------------------------------|--------|
|                                                     |   | December      31, 2007 |     |   | September      30, 2007 |   |
|                                                     |   |                        |     |   |                         |   |
| Net      loss                                            |   |                        |     |   |                         |   |
| Other      comprehensive income (loss)                   |   | $                           | (173,274 | )      |                         | $      | (898,376 | ) |
|   Foreign currency      translation adjustment |   |                        | 57,552   |   |                         |   | 167,424 |   |
|                                                     |   |                        |     |   |                         |   |   |   |
|   Net comprehensive      income (loss)         |   | $                           | (115,722 | )      |                         | $      | (730,952 | ) |

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|                                                                  |   | Common      Stock |       |   | Additional      Paid      in |   |   |    |   |
|-----------------------------------------------------------------------|--------|-------------------|------------|--------|------------------------------|--------|--------|---------|--------|
|                                                                  |   | Shares            |       |   | Amount                       |   |   | Capital |   |   | Deficit |   |
|                                                                  |   |              |       |   |                         |   |   |    |   |   |   |   |
| Balance - September 30,      2005                                     |   |              | 4,744,425  |   |                         | $      | 474    |    |   | $ | 3,920,512 |   |   | $ | (4,563,522 | ) |
|                                                                  |   |              |       |   |                         |   |   |    |   |   |   |   |   |   |   |   |
|   Shares issued for      debts                              |   |              | 1,594,800  |   |                         |   | 160    |    |   |   | 445,020 |   |   |   | - |   |
|   Shares issued for      services                           |   |              | 54,512     |   |                         |   | 5      |    |   |   | 33,995 |   |   |   | - |   |
|   Shares issued for      private placement                  |   |              | 4,224,000  |   |                         |   | 422    |    |   |   | 1,287,098 |   |   |   | - |   |
|   Shares issued for      option exercise                    |   |              | 250,000    |   |                         |   | 25     |    |   |   | 99,975 |   |   |   | - |   |
|   Net loss for the      year ended September 30, 2006       |   |              | -          |   |                         |   | -      |    |   |   | - |   |   |   | (1,509,633 | ) |
|                                                                  |   |              |       |   |                         |   |   |    |   |   |   |   |   |   |   |   |
| Balance - September 30,      2006                                     |   |              | 10,867,737 |   |                         | $      | 1,086  |    |   | $ | 5,786,600 |   |   | $ | (6,073,155 | ) |
|                                                                  |   |              |       |   |                         |   |   |    |   |   |   |   |   |   |   |   |
|   Shares issued for      debts                              |   |              | 3,920,593  |   |                         |   | 392    |    |   |   | 217,811 |   |   |   | - |   |
|   Shares issued for      services                           |   |              | 9,498,333  |   |                         |   | 951    |    |   |   | 560,185 |   |   |   | - |   |
|   Shares issued for      private placement                  |   |              | 272,000    |   |                         |   | 27     |    |   |   | 64,993 |   |   |   | - |   |
|   Shares issued for      acquisition of Scanview            |   |              | 2,500,000  |   |                         |   | 250    |    |   |   | 174,750 |   |   |   | - |   |
|   Net loss for the      year ended September 30, 2007       |   |              | -          |   |                         |   | -      |    |   |   | - |   |   |   | (898,376 | ) |
|                                                                  |   |              |       |   |                         |   |   |    |   |   |   |   |   |   |   |   |
| Balance      – September 30, 2007                               |   |              | 27,058,663 |   |                         | $      | 2706   |    |   | $ | 6,804,339 |   |   | $ | (6,971,531 | ) |
|                                                                  |   |              |       |   |                         |   |   |    |   |   |   |   |   |   |   |   |
|   Net loss for the      period ended December 31,      2007 |   |              | -          |   |                         |   | -      |    |   |   | - |   |   |   | (173,275 | ) |
|                                                                  |   |              |       |   |                         |   |   |    |   |   |   |   |   |   |   |   |
| Balance      – December 31, 2007                                |   |              | 27,058,663 |   |                         | $      | 2,706  |    |   | $ | 6,804,339 |   |   | $ | (7,144,806 | ) |
|                                                                  |   |              |       |   |                         |   |   |    |   |   |   |   |   |   |   |   |

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|                          |   | December      31, |          |   | September      30, |   |
|-------------------------------|--------|-------------------|---------------|--------|--------------------|--------|
|                          |   | 2007              |          |   | 2007               |   |
|                          |   |              |          |   |               |   |
| Raw      materials            |   | $                 | 146,249       |   |               | $      | 159,697 |   |
| Work      in process          |   |              | 11,376        |   |               |   | 13,376 |   |
| Finished      goods           |   |              | 22,449        |   |               |   | 21,753 |   |
|                          |   |              |          |   |               |   |   |   |
|     Total |   | $                 | 180,      074 |   |               | $      | 194,826 |   |

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|               |   | December      31, |   |   | September      30, |   |
|--------------------|--------|-------------------|--------|--------|--------------------|--------|
|               |   | 2007              |   |   | 2007               |   |
|               |   |              |   |   |               |   |
| R&D      Costs |   | $                 | 55,064 |   |               | $      | 163,712 |   |
| Less      Credit   |   |              | -      |   |               |   | (29,418 | ) |
|               |   | $                 | 55,064 |   |               | $      | 134,294 |   |

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

execute its business plan.

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----

the company is engaged in the following legalproceedings:

|  Medical International      Technology,Inc.        |   Quarterly Financial      Report |
|--------------------------------------------------------------------------------------------|----------------------------------------|

----